Connected Insulin Pen Solutions

About Diabeloop

Diabeloop is a Grenoble-based medtech pioneer commercializing a CE-marked and FDA-authorized AID system (DBLG2) for Type 1 diabetes, powered by a self-learning AI algorithm. The company has secured significant funding (€70M Series C in 2022) and established key international partnerships with major diabetes care players like Roche, Terumo, and Novo Nordisk to drive expansion. Its strategy focuses on interoperability, extending its AI platform to connected insulin pens for Type 2 diabetes, and pursuing global market access in the US, Japan, and Korea.

Therapeutic Areas